Feasibility and efficacy of remimazolam for anesthesia monitoring in transcatheter aortic valve implantation via femoral artery access
American Journal of Translational Research · 2025 · 17 (5) · 3530-3537
DOI: 10.62347/qumd4078 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2025. Verfasst von Xin Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China.
- Guangdong Medical University Dongguan 523808, Guangdong, China.
Zitieren
APA
Liang, X., Deng, X., Lao, Q., Chen, L., Liang, Y., & Yang, L. (2025). Feasibility and efficacy of remimazolam for anesthesia monitoring in transcatheter aortic valve implantation via femoral artery access. American Journal of Translational Research, 17(5), 3530-3537. https://doi.org/10.62347/qumd4078
Vancouver
Liang X, Deng X, Lao Q, Chen L, Liang Y, Yang L. Feasibility and efficacy of remimazolam for anesthesia monitoring in transcatheter aortic valve implantation via femoral artery access. American Journal of Translational Research. 2025;17(5):3530-3537. doi:10.62347/qumd4078
BibTeX
@article{Liang2025,
author = {Liang, Xin and Deng, Xin and Lao, Qiying and Chen, Longqian and Liang, Yanli and Yang, Liu},
title = {Feasibility and efficacy of remimazolam for anesthesia monitoring in transcatheter aortic valve implantation via femoral artery access},
journal = {American Journal of Translational Research},
year = {2025},
volume = {17},
number = {5},
pages = {3530--3537},
doi = {10.62347/qumd4078}
}
EUVIMED